A few studies suggested that stopping GLP-1s is associated with regaining at least a portion of the lost weight, but its possible that if you go slowly, you may be more likely to keep the weight off
Maintaining weight loss after stopping GLP-1 medications requires adopting habits that support your metabolism and help manage hunger
The benefits of Rybelsus in managing type 2 diabetes may outweigh the risks of side effects for many individuals, especially with proper management and adherence to the prescribed regimen
Safety Profiles: Analyzing Risks and Side Effects of Tirzepatide and Semaglutide Semaglutide and another GLP-1 receptor agonist share similar side effects, primarily such as nausea, vomiting, and diarrhea
One suggested practice to managing GI AEs is the Three Es method, which comprises 1) education and explanation, 2) escalation to an appropriate dose, and 3) effective management of GI AEs
Ideally two weeks if the patient is on the 10mg or 15mg dose
